Home Therapeutics Therapeutics ICON's global team of experts has extensive experience in a broad range of therapeutic areas Oncology This is our fastest-growing therapeutic area and testament to success in conducting oncology clinical trials. Central Nervous System Global and regional studies in all major areas of psychiatry, neurology, and pain research. Vaccines Offering development expertise and clinical trial experience in this complex area. Cell and Gene Therapies Accelerating study start-up and delivering results with custom strategies and logistics solutions. Cardiovascular Extensive experience in cardiovascular trials. Endocrine & Metabolic Disorders Global studies in endocrine & metabolic disorders is one of our strengths. Gastrointestinal Extensive experience in managing clinical studies in all major gastrointestinal indications. Hepatology Offering expertise in the development and management of all aspects of MASH clinical trials. Ophthalmology Leading solutions and services to optimise pharmaceutical and device development. Rare & Orphan Diseases Driving better diagosis and treatments through deep expertise and genomics data. Respiratory Expertise in respiratory clinical trials for drugs, devices, and drug-device combinations. Biosimilars ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars. Autoimmune Diseases Anticipating challenges to ensure efficient operations, patient safety and strong evidence. Internal Medicine & Immunology ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars. Women's Health Therapeutics Specialist expertise and experience to address every stage of your women’s health program. Paediatrics Driving paediatric clinical research forward and protecting kids through research—not from it. ICON has been recognised for having 'exceeded customer expectations’ for ‘therapeutic expertise’ in the 2024 CRO Leadership Awards. ICON was the most awarded CRO across over 20 performance metrics. What’s happening in ICON